Michel Janicot

JNJ-26481585, a Novel Second-Generation Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity

Janine Arts, Peter King, Ann Marin et al. · Clinical Cancer Research · 2009 · 232 citations

Medicine, Oncology, Pharmacology +12

Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles

Suzie H. Pun, Frederik Tack, Nathalie C. Bellocq et al. · Cancer Biology & Therapy · 2004 · 200 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Critical Role of the Ubiquitin Ligase Activity of UHRF1, a Nuclear RING Finger Protein, in Tumor Cell Growth

Yonchu Jenkins, Vadim Markovtsov, Wayne Lang et al. · Molecular Biology of the Cell · 2005 · 183 citations · Full text

Medicine, Cancer Biology, Oncology +17

Disruption of Murine Mus81 Increases Genomic Instability and DNA Damage Sensitivity but Does Not Promote Tumorigenesis

Najoua Dendouga, Hui Gao, Dieder Moechars et al. · Molecular and Cellular Biology · 2005 · 149 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

Promoter-cDNA-directed heterologous protein expression in Xenopus laevis oocytes.

Andrew G. Swick, Michel Janicot, T Cheneval-Kastelic et al. · Proceedings of the National Academy of Sciences · 1992 · 115 citations

Life Sciences, Genetics, Molecular Biology +13